1 Biological Drugs Market Overview 1.1 Product Overview and Scope of Biological Drugs 1.2 Biological Drugs Segment by Type 1.2.1 Global Biological Drugs Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Therapeutic Protein 1.2.3 Monoclonal Antibody 1.2.4 Vaccine 1.2.5 Others 1.3 Biological Drugs Segment by Application 1.3.1 Global Biological Drugs Sales Comparison by Application: (2022-2028) 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.3.4 Others 1.4 Global Biological Drugs Market Size Estimates and Forecasts 1.4.1 Global Biological Drugs Revenue 2017-2028 1.4.2 Global Biological Drugs Sales 2017-2028 1.4.3 Biological Drugs Market Size by Region: 2017 Versus 2021 Versus 2028 2 Biological Drugs Market Competition by Manufacturers 2.1 Global Biological Drugs Sales Market Share by Manufacturers (2017-2022) 2.2 Global Biological Drugs Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Biological Drugs Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Biological Drugs Manufacturing Sites, Area Served, Product Type 2.5 Biological Drugs Market Competitive Situation and Trends 2.5.1 Biological Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Biological Drugs Players Market Share by Revenue 2.5.3 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Biological Drugs Retrospective Market Scenario by Region 3.1 Global Biological Drugs Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Biological Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Biological Drugs Market Facts & Figures by Country 3.3.1 North America Biological Drugs Sales by Country 3.3.2 North America Biological Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Biological Drugs Market Facts & Figures by Country 3.4.1 Europe Biological Drugs Sales by Country 3.4.2 Europe Biological Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Biological Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Biological Drugs Sales by Region 3.5.2 Asia Pacific Biological Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Biological Drugs Market Facts & Figures by Country 3.6.1 Latin America Biological Drugs Sales by Country 3.6.2 Latin America Biological Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Biological Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Biological Drugs Sales by Country 3.7.2 Middle East and Africa Biological Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Biological Drugs Historic Market Analysis by Type 4.1 Global Biological Drugs Sales Market Share by Type (2017-2022) 4.2 Global Biological Drugs Revenue Market Share by Type (2017-2022) 4.3 Global Biological Drugs Price by Type (2017-2022) 5 Global Biological Drugs Historic Market Analysis by Application 5.1 Global Biological Drugs Sales Market Share by Application (2017-2022) 5.2 Global Biological Drugs Revenue Market Share by Application (2017-2022) 5.3 Global Biological Drugs Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Bristol-Myers Squibb 6.1.1 Bristol-Myers Squibb Corporation Information 6.1.2 Bristol-Myers Squibb Description and Business Overview 6.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Bristol-Myers Squibb Biological Drugs Product Portfolio 6.1.5 Bristol-Myers Squibb Recent Developments/Updates 6.2 Eli Lilly 6.2.1 Eli Lilly Corporation Information 6.2.2 Eli Lilly Description and Business Overview 6.2.3 Eli Lilly Biological Drugs Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Eli Lilly Biological Drugs Product Portfolio 6.2.5 Eli Lilly Recent Developments/Updates 6.3 Takeda 6.3.1 Takeda Corporation Information 6.3.2 Takeda Description and Business Overview 6.3.3 Takeda Biological Drugs Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Takeda Biological Drugs Product Portfolio 6.3.5 Takeda Recent Developments/Updates 6.4 Pfizer 6.4.1 Pfizer Corporation Information 6.4.2 Pfizer Description and Business Overview 6.4.3 Pfizer Biological Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Pfizer Biological Drugs Product Portfolio 6.4.5 Pfizer Recent Developments/Updates 6.5 Amgen 6.5.1 Amgen Corporation Information 6.5.2 Amgen Description and Business Overview 6.5.3 Amgen Biological Drugs Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Amgen Biological Drugs Product Portfolio 6.5.5 Amgen Recent Developments/Updates 6.6 F. Hoffmann-La Roche 6.6.1 F. Hoffmann-La Roche Corporation Information 6.6.2 F. Hoffmann-La Roche Description and Business Overview 6.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue and Gross Margin (2017-2022) 6.6.4 F. Hoffmann-La Roche Biological Drugs Product Portfolio 6.6.5 F. Hoffmann-La Roche Recent Developments/Updates 6.7 Johnson & Johnson 6.6.1 Johnson & Johnson Corporation Information 6.6.2 Johnson & Johnson Description and Business Overview 6.6.3 Johnson & Johnson Biological Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Johnson & Johnson Biological Drugs Product Portfolio 6.7.5 Johnson & Johnson Recent Developments/Updates 6.8 Merck 6.8.1 Merck Corporation Information 6.8.2 Merck Description and Business Overview 6.8.3 Merck Biological Drugs Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Merck Biological Drugs Product Portfolio 6.8.5 Merck Recent Developments/Updates 6.9 Abbott Laboratories 6.9.1 Abbott Laboratories Corporation Information 6.9.2 Abbott Laboratories Description and Business Overview 6.9.3 Abbott Laboratories Biological Drugs Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Abbott Laboratories Biological Drugs Product Portfolio 6.9.5 Abbott Laboratories Recent Developments/Updates 6.10 Baxter 6.10.1 Baxter Corporation Information 6.10.2 Baxter Description and Business Overview 6.10.3 Baxter Biological Drugs Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Baxter Biological Drugs Product Portfolio 6.10.5 Baxter Recent Developments/Updates 6.11 Novartis 6.11.1 Novartis Corporation Information 6.11.2 Novartis Biological Drugs Description and Business Overview 6.11.3 Novartis Biological Drugs Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Novartis Biological Drugs Product Portfolio 6.11.5 Novartis Recent Developments/Updates 6.12 Biogen 6.12.1 Biogen Corporation Information 6.12.2 Biogen Biological Drugs Description and Business Overview 6.12.3 Biogen Biological Drugs Sales, Revenue and Gross Margin (2017-2022) 6.12.4 Biogen Biological Drugs Product Portfolio 6.12.5 Biogen Recent Developments/Updates 6.13 GlaxoSmithKline 6.13.1 GlaxoSmithKline Corporation Information 6.13.2 GlaxoSmithKline Biological Drugs Description and Business Overview 6.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue and Gross Margin (2017-2022) 6.13.4 GlaxoSmithKline Biological Drugs Product Portfolio 6.13.5 GlaxoSmithKline Recent Developments/Updates 7 Biological Drugs Manufacturing Cost Analysis 7.1 Biological Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Biological Drugs 7.4 Biological Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Biological Drugs Distributors List 8.3 Biological Drugs Customers 9 Biological Drugs Market Dynamics 9.1 Biological Drugs Industry Trends 9.2 Biological Drugs Market Drivers 9.3 Biological Drugs Market Challenges 9.4 Biological Drugs Market Restraints 10 Global Market Forecast 10.1 Biological Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Biological Drugs by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Biological Drugs by Type (2023-2028) 10.2 Biological Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Biological Drugs by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Biological Drugs by Application (2023-2028) 10.3 Biological Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Biological Drugs by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Biological Drugs by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Biological Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Biological Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Biological Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Biological Drugs Market Competitive Situation by Manufacturers in 2021 Table 5. Global Biological Drugs Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Biological Drugs Sales Market Share by Manufacturers (2017-2022) Table 7. Global Biological Drugs Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Biological Drugs Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Biological Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Biological Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Biological Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Biological Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biological Drugs as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Biological Drugs Sales by Region (2017-2022) & (K Units) Table 16. Global Biological Drugs Sales Market Share by Region (2017-2022) Table 17. Global Biological Drugs Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Biological Drugs Revenue Market Share by Region (2017-2022) Table 19. North America Biological Drugs Sales by Country (2017-2022) & (K Units) Table 20. North America Biological Drugs Sales Market Share by Country (2017-2022) Table 21. North America Biological Drugs Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Biological Drugs Revenue Market Share by Country (2017-2022) Table 23. Europe Biological Drugs Sales by Country (2017-2022) & (K Units) Table 24. Europe Biological Drugs Sales Market Share by Country (2017-2022) Table 25. Europe Biological Drugs Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Biological Drugs Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Biological Drugs Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Biological Drugs Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Biological Drugs Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Biological Drugs Revenue Market Share by Region (2017-2022) Table 31. Latin America Biological Drugs Sales by Country (2017-2022) & (K Units) Table 32. Latin America Biological Drugs Sales Market Share by Country (2017-2022) Table 33. Latin America Biological Drugs Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Biological Drugs Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Biological Drugs Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Biological Drugs Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Biological Drugs Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Biological Drugs Revenue Market Share by Country (2017-2022) Table 39. Global Biological Drugs Sales by Type (2017-2022) & (K Units) Table 40. Global Biological Drugs Sales Market Share by Type (2017-2022) Table 41. Global Biological Drugs Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Biological Drugs Revenue Share by Type (2017-2022) Table 43. Global Biological Drugs Price by Type (2017-2022) & (USD/Unit) Table 44. Global Biological Drugs Sales (K Units) by Application (2017-2022) Table 45. Global Biological Drugs Sales Market Share by Application (2017-2022) Table 46. Global Biological Drugs Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Biological Drugs Revenue Share by Application (2017-2022) Table 48. Global Biological Drugs Price by Application (2017-2022) & (USD/Unit) Table 49. Bristol-Myers Squibb Corporation Information Table 50. Bristol-Myers Squibb Description and Business Overview Table 51. Bristol-Myers Squibb Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 52. Bristol-Myers Squibb Biological Drugs Product Table 53. Bristol-Myers Squibb Recent Developments/Updates Table 54. Eli Lilly Corporation Information Table 55. Eli Lilly Description and Business Overview Table 56. Eli Lilly Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 57. Eli Lilly Biological Drugs Product Table 58. Eli Lilly Recent Developments/Updates Table 59. Takeda Corporation Information Table 60. Takeda Description and Business Overview Table 61. Takeda Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 62. Takeda Biological Drugs Product Table 63. Takeda Recent Developments/Updates Table 64. Pfizer Corporation Information Table 65. Pfizer Description and Business Overview Table 66. Pfizer Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 67. Pfizer Biological Drugs Product Table 68. Pfizer Recent Developments/Updates Table 69. Amgen Corporation Information Table 70. Amgen Description and Business Overview Table 71. Amgen Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 72. Amgen Biological Drugs Product Table 73. Amgen Recent Developments/Updates Table 74. F. Hoffmann-La Roche Corporation Information Table 75. F. Hoffmann-La Roche Description and Business Overview Table 76. F. Hoffmann-La Roche Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. F. Hoffmann-La Roche Biological Drugs Product Table 78. F. Hoffmann-La Roche Recent Developments/Updates Table 79. Johnson & Johnson Corporation Information Table 80. Johnson & Johnson Description and Business Overview Table 81. Johnson & Johnson Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Johnson & Johnson Biological Drugs Product Table 83. Johnson & Johnson Recent Developments/Updates Table 84. Merck Corporation Information Table 85. Merck Description and Business Overview Table 86. Merck Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. Merck Biological Drugs Product Table 88. Merck Recent Developments/Updates Table 89. Abbott Laboratories Corporation Information Table 90. Abbott Laboratories Description and Business Overview Table 91. Abbott Laboratories Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. Abbott Laboratories Biological Drugs Product Table 93. Abbott Laboratories Recent Developments/Updates Table 94. Baxter Corporation Information Table 95. Baxter Description and Business Overview Table 96. Baxter Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. Baxter Biological Drugs Product Table 98. Baxter Recent Developments/Updates Table 99. Novartis Corporation Information Table 100. Novartis Description and Business Overview Table 101. Novartis Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 102. Novartis Biological Drugs Product Table 103. Novartis Recent Developments/Updates Table 104. Biogen Corporation Information Table 105. Biogen Description and Business Overview Table 106. Biogen Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 107. Biogen Biological Drugs Product Table 108. Biogen Recent Developments/Updates Table 109. GlaxoSmithKline Corporation Information Table 110. GlaxoSmithKline Description and Business Overview Table 111. GlaxoSmithKline Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 112. GlaxoSmithKline Biological Drugs Product Table 113. GlaxoSmithKline Recent Developments/Updates Table 114. Production Base and Market Concentration Rate of Raw Material Table 115. Key Suppliers of Raw Materials Table 116. Biological Drugs Distributors List Table 117. Biological Drugs Customers List Table 118. Biological Drugs Market Trends Table 119. Biological Drugs Market Drivers Table 120. Biological Drugs Market Challenges Table 121. Biological Drugs Market Restraints Table 122. Global Biological Drugs Sales Forecast by Type (2023-2028) & (K Units) Table 123. Global Biological Drugs Sales Market Share Forecast by Type (2023-2028) Table 124. Global Biological Drugs Revenue Forecast by Type (2023-2028) & (US$ Million) Table 125. Global Biological Drugs Revenue Market Share Forecast by Type (2023-2028) Table 126. Global Biological Drugs Sales Forecast by Application (2023-2028) & (K Units) Table 127. Global Biological Drugs Sales Market Share Forecast by Application (2023-2028) Table 128. Global Biological Drugs Revenue Forecast by Application (2023-2028) & (US$ Million) Table 129. Global Biological Drugs Revenue Market Share Forecast by Application (2023-2028) Table 130. Global Biological Drugs Sales Forecast by Region (2023-2028) & (K Units) Table 131. Global Biological Drugs Sales Market Share Forecast by Region (2023-2028) Table 132. Global Biological Drugs Revenue Forecast by Region (2023-2028) & (US$ Million) Table 133. Global Biological Drugs Revenue Market Share Forecast by Region (2023-2028) Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Biological Drugs Figure 2. Global Biological Drugs Market Share by Type in 2021 & 2028 Figure 3. Therapeutic Protein Product Picture Figure 4. Monoclonal Antibody Product Picture Figure 5. Vaccine Product Picture Figure 6. Others Product Picture Figure 7. Global Biological Drugs Market Share by Application in 2021 & 2028 Figure 8. Hospitals Figure 9. Ambulatory Surgical Centers Figure 10. Others Figure 11. Global Biological Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Biological Drugs Market Size (2017-2028) & (US$ Million) Figure 13. Global Biological Drugs Sales (2017-2028) & (K Units) Figure 14. Biological Drugs Sales Share by Manufacturers in 2021 Figure 15. Global Biological Drugs Revenue Share by Manufacturers in 2021 Figure 16. The Global 5 and 10 Largest Biological Drugs Players: Market Share by Revenue in 2021 Figure 17. Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 18. Global Biological Drugs Sales Market Share by Region (2017-2022) Figure 19. Global Biological Drugs Sales Market Share by Region in 2021 Figure 20. Global Biological Drugs Revenue Market Share by Region (2017-2022) Figure 21. Global Biological Drugs Revenue Market Share by Region in 2021 Figure 22. U.S. Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. Canada Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. Germany Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. France Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. U.K. Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Italy Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Russia Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. China Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. Japan Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. South Korea Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. India Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Australia Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Taiwan Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Indonesia Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Thailand Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Malaysia Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Philippines Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Vietnam Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Mexico Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Brazil Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Argentina Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Turkey Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Saudi Arabia Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. U.A.E Biological Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 46. Sales Market Share of Biological Drugs by Type (2017-2022) Figure 47. Manufacturing Cost Structure of Biological Drugs Figure 48. Manufacturing Process Analysis of Biological Drugs Figure 49. Biological Drugs Industrial Chain Analysis Figure 50. Channels of Distribution Figure 51. Distributors Profiles Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Bristol-Myers Squibb Eli Lilly Takeda Pfizer Amgen F. Hoffmann-La Roche Johnson & Johnson Merck Abbott Laboratories Baxter Novartis Biogen GlaxoSmithKline